Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study

2018188 citationsJournal Article

Authors

The addition of veliparib to frontline chemotherapy showed signal of efficacy in patients with ES-SCLC and the study met its prespecified end point.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 37, Issue 3, pp. 222-229

Field-Weighted Citation Impact: 7.71